Profile data is unavailable for this security.
About the company
Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.
- Revenue in USD (TTM)65.71m
- Net income in USD-52.79m
- Incorporated2007
- Employees727.00
- LocationConcord Medical Services Holdings LtdRoom 26A1-26A5, East Tower, Hanwei, BuilBEIJING 100020ChinaCHN
- Phone+86 1 058256867
- Websitehttps://www.concordmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Health Systems Inc | 0.00 | -1.02m | 13.48m | 2.00 | -- | 6.75 | -- | -- | -0.0928 | -0.0928 | 0.00 | 0.1482 | 0.00 | -- | -- | 0.00 | -45.80 | -14.62 | -66.91 | -19.89 | -- | -- | -- | -36.77 | -- | -- | 0.00 | -- | -- | -- | 38.97 | -- | -- | -- |
| Psychemedics Corp. | 20.79m | -4.56m | 13.79m | 116.00 | -- | 2.37 | -- | 0.6635 | -0.7882 | -0.7882 | 3.59 | 0.9858 | 1.57 | -- | 5.89 | 179,198.30 | -34.41 | -7.44 | -53.29 | -9.70 | 37.63 | 37.55 | -21.93 | -6.26 | -- | -264.69 | 0.1198 | -- | -12.45 | -12.33 | -283.21 | -- | -33.32 | -- |
| Interpace Biosciences Inc | 44.89m | 4.89m | 14.40m | 108.00 | 2.96 | -- | 2.79 | 0.3208 | 1.10 | 1.06 | 10.13 | -- | -- | -- | -- | 415,675.90 | -- | -38.19 | -- | -69.73 | 60.46 | 49.44 | 10.88 | -41.01 | -- | 8.11 | -- | -- | 26.31 | 12.93 | 118.96 | -- | 0.9184 | -- |
| ProPhase Labs Inc | 17.97m | -26.31m | 14.88m | 113.00 | -- | 0.3376 | -- | 0.828 | -1.46 | -1.46 | 0.9962 | 2.31 | 0.1946 | 5.24 | 0.5027 | 159,044.30 | -28.48 | 0.9106 | -36.78 | 1.12 | -9.11 | 50.32 | -146.39 | 0.9325 | 1.44 | -17.99 | 0.2469 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
| PharmChem Inc | 5.98m | 1.14m | 15.80m | 170.00 | 14.09 | 5.76 | 13.86 | 2.64 | 0.2414 | 0.2414 | 1.26 | 0.5903 | 1.83 | 9.25 | 8.71 | -- | 34.87 | -- | 42.91 | -- | 64.49 | -- | 19.05 | -- | 5.20 | -- | 0.00 | -- | 3.50 | -- | -16.95 | -- | -- | -- |
| Oncology Institute Inc | 361.07m | -58.51m | 19.63m | 800.00 | -- | 0.672 | -- | 0.0544 | -0.7898 | -0.7898 | 4.87 | 0.3869 | 1.76 | 26.03 | 7.19 | 451,333.80 | -34.94 | -- | -41.97 | -- | 15.33 | 19.54 | -19.81 | -9.99 | 2.99 | -7.80 | 0.7549 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| Aesthetic Medical Intl Hldg Grp Ltd(ADR) | 101.23m | -6.75m | 21.79m | 1.29k | -- | 5.61 | 10.91 | 0.2153 | -0.1497 | -0.1497 | 2.23 | 0.0812 | 1.29 | 20.82 | 77.36 | 78,715.59 | -9.06 | -23.36 | -35.45 | -48.58 | 45.39 | 55.32 | -7.02 | -23.72 | 0.2031 | -5.50 | 0.9581 | -- | 1.86 | -2.16 | 50.91 | -- | 3.70 | -- |
| Concord Medical Services Hldgs Ltd (ADR) | 65.71m | -52.79m | 23.79m | 727.00 | -- | -- | -- | 0.3621 | -12.08 | -12.08 | 15.04 | -68.62 | 0.0743 | 13.39 | 5.35 | 90,385.10 | -10.23 | -9.49 | -111.95 | -39.24 | -17.13 | -15.06 | -137.67 | -134.56 | 0.4556 | -1.89 | 0.6369 | -- | 13.84 | 23.00 | 39.21 | -- | -6.88 | -- |
| Burning Rock Biotech Ltd (ADR) | 71.02m | -78.96m | 35.29m | 786.00 | -- | 0.3732 | -- | 0.4969 | -49.01 | -49.01 | 12.59 | 9.22 | 0.4331 | 1.97 | 2.68 | 90,354.45 | -48.15 | -37.09 | -65.09 | -45.29 | 67.71 | 70.02 | -111.18 | -123.88 | 2.85 | -- | 0.00 | -- | -4.58 | 20.81 | 32.69 | -- | -17.61 | -- |
Data as of Nov 11 2024. Currency figures normalised to Concord Medical Services Holdings Ltd's reporting currency: US Dollar USD
0.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 30 Jun 2024 | 3.91k | 0.14% |
| RhumbLine Advisers LPas of 30 Jun 2024 | 1.99k | 0.07% |
| XTX Markets LLCas of 30 Jun 2024 | 1.41k | 0.05% |
| UBS Securities LLCas of 30 Jun 2024 | 816.00 | 0.03% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
